Hydroxyurea reduces infections in children with sickle cell anemia in Uganda.
Journal
Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509
Informations de publication
Date de publication:
03 Jan 2024
03 Jan 2024
Historique:
accepted:
16
12
2023
received:
21
06
2023
revised:
11
12
2023
medline:
4
1
2024
pubmed:
4
1
2024
entrez:
3
1
2024
Statut:
aheadofprint
Résumé
After starting hydroxyurea treatment, Ugandan children with sickle cell anemia had 60% less severe or invasive infections, including malaria, bacteremia, respiratory tract infections and gastroenteritis, than before starting hydroxyurea treatment (incidence rate ratio =0.40 [95% confidence interval], 0.29-0.54, P<0.001).
Identifiants
pubmed: 38169476
pii: 506920
doi: 10.1182/blood.2023021575
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 American Society of Hematology.